Irinotecan plus leucovorin-modulated 5-fluorouracil I.V. bolus every other week may be a suitable therapeutic option also for elderly patients with metastatic colorectal carcinoma

The aim of this study was to assess the safety and efficacy of biweekly irinotecan plus leucovorin-modulated 5-fluorouracil i.v. bolus in metastatic colorectal carcinoma according to the age of patients. For this purpose, we have analysed 108 patients randomly allocated to receive irinotecan 200 mg ...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Comella, P, Farris, A, Lorusso, V, Palmeri, S, Maiorino, L, Lucia, L De, Buzzi, F, Mancarella, S, Vita, F De, Gambardella, A
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2003
Teme:
Clinical
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2376956/
https://ncbi.nlm.nih.gov/pubmed/12966414
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6601214
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki